Actavis Elizabeth LLC

Form 483 issued February 15, 2017 · Elizabeth, New Jersey

Inspection
Jan 23 – Feb 15, 2017
Observations
1
Pages
2
FEI number
2211563

In short: On February 15, 2017, FDA issued a Form 483 with 1 observation to Actavis Elizabeth LLC in Elizabeth, New Jersey (FEI 2211563) after an inspection that ran Jan 23 – Feb 15, 2017. The investigators were Guerlain Ulysse, Sachinkumar V. Patel and Yvesna Blaise. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.165 (testing and release for distribution).

At a glance

1 of 1 observations on this 483 concern laboratory controls.

Laboratory controls1

Most cited: 21 CFR 211.165 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Actavis Elizabeth LLC?

FDA listed 1 observation on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.165 (testing and release for distribution). The opening words of each observation are shown on this page.

Who inspected Actavis Elizabeth LLC?

Guerlain Ulysse, Sachinkumar V. Patel and Yvesna Blaise are named on this Form 483, for the inspection of Jan 23 – Feb 15, 2017. Each investigator has a profile showing what they cite most.

When was Actavis Elizabeth LLC inspected by FDA?

The inspection ran Jan 23 – Feb 15, 2017, and the Form 483 is dated February 15, 2017.

How do I get the full Form 483 for Actavis Elizabeth LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free